Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000526740 | SCV000651131 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-12-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001557711 | SCV001779522 | likely benign | not provided | 2019-09-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367921 | SCV002665046 | likely benign | Cardiovascular phenotype | 2019-12-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001557711 | SCV002034203 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001557711 | SCV002036572 | likely benign | not provided | no assertion criteria provided | clinical testing |